The paper describes a cohort of patients with post-acute COVID-19 syndrome, evaluated for the first time between week 3 and week 12 from the onset of symptoms following the acute COVID-19 infection. The patient's baseline clinical features were used as predictors. The analysis showed that older patients with comorbidities are at higher risk of developing more long-lasting post COVID-19 symptoms. Further integration with a personal monitoring device and combination with the Fast Healthcare Interoperability Resources extends the standardization, interoperability and possibility of integration and harmonization with other hospital systems. By employing advanced machine learning techniques, insights can be derived and further examined to improve the outcome and early treatment options for patients.
{"title":"ML-Based Framework to Predict the Severity of the Symptomatology in Patients with Post-Acute COVID-19 Syndrome.","authors":"Adina Nitulescu, Mihaela Crisan-Vida, Cristina Tudoran, Lacramioara Stoicu-Tivadar","doi":"10.3233/SHTI241071","DOIUrl":"https://doi.org/10.3233/SHTI241071","url":null,"abstract":"<p><p>The paper describes a cohort of patients with post-acute COVID-19 syndrome, evaluated for the first time between week 3 and week 12 from the onset of symptoms following the acute COVID-19 infection. The patient's baseline clinical features were used as predictors. The analysis showed that older patients with comorbidities are at higher risk of developing more long-lasting post COVID-19 symptoms. Further integration with a personal monitoring device and combination with the Fast Healthcare Interoperability Resources extends the standardization, interoperability and possibility of integration and harmonization with other hospital systems. By employing advanced machine learning techniques, insights can be derived and further examined to improve the outcome and early treatment options for patients.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"99-103"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tingyan Xu, Timo Wolters, Johannes Lotz, Tom Bisson, Tim-Rasmus Kiehl, Nadine Flinner, Norman Zerbe, Marco Eichelberg
The PROSurvival project aims to improve the prediction of recurrence-free survival in prostate cancer by applying federated machine learning to whole slide images combined with selected clinical data. Both the image and clinical data will be aggregated into an anonymized dataset compliant with the General Data Protection Regulation and published under the principles of findable, accessible, interoperable, and reusable data. The DICOM standard will be used for the image data. For the accompanying clinical data, a human-readable, compact and flexible standard is yet to be defined. From the set of existing standards, mostly extendable with varying degrees of modifications, we chose oBDS as a starting point and modified it to include missing data points and to remove mandatory items not applicable to our dataset. Clinical and survival data from clinic-specific spreadsheets were converted into this modified standard, ensuring on-site data privacy during processing. For publication of the dataset, both image and clinical data are anonymized using established methods. The key challenges arose during the clinical data anonymization and in identifying research repositories meeting all of our requirements. Each clinic had to coordinate the publication with their responsible data protection officers, requiring different approval processes due to the individual states' differing interpretations of the legal regulations. The newly established German Health Data Utilization Act is expected to simplify future data sharing in a responsible and powerful way.
{"title":"PROSurvival: A Technical Case Report on Creating and Publishing a Dataset for Federated Learning on Survival Prediction of Prostate Cancer Patients.","authors":"Tingyan Xu, Timo Wolters, Johannes Lotz, Tom Bisson, Tim-Rasmus Kiehl, Nadine Flinner, Norman Zerbe, Marco Eichelberg","doi":"10.3233/SHTI241096","DOIUrl":"https://doi.org/10.3233/SHTI241096","url":null,"abstract":"<p><p>The PROSurvival project aims to improve the prediction of recurrence-free survival in prostate cancer by applying federated machine learning to whole slide images combined with selected clinical data. Both the image and clinical data will be aggregated into an anonymized dataset compliant with the General Data Protection Regulation and published under the principles of findable, accessible, interoperable, and reusable data. The DICOM standard will be used for the image data. For the accompanying clinical data, a human-readable, compact and flexible standard is yet to be defined. From the set of existing standards, mostly extendable with varying degrees of modifications, we chose oBDS as a starting point and modified it to include missing data points and to remove mandatory items not applicable to our dataset. Clinical and survival data from clinic-specific spreadsheets were converted into this modified standard, ensuring on-site data privacy during processing. For publication of the dataset, both image and clinical data are anonymized using established methods. The key challenges arose during the clinical data anonymization and in identifying research repositories meeting all of our requirements. Each clinic had to coordinate the publication with their responsible data protection officers, requiring different approval processes due to the individual states' differing interpretations of the legal regulations. The newly established German Health Data Utilization Act is expected to simplify future data sharing in a responsible and powerful way.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"220-224"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142688780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The present study explored alternative methods for photographing skin lesions in the absence of specialized instruments like dermatoscopes, aiming to enhance remote diagnostic capabilities, particularly in light of the increasing incidence of melanoma cases annually. Using two lenses attached to a smartphone camera, one macroscopic and the other microscopic, study images of nevus formations from one individual were captured, and, in the absence of a collaboration with a dermatologist, subsequently labeled as melanoma or non-melanoma using a Convolutional Neural Network (CNN) which was trained, with dermoscopic images of melanoma and non-melanoma formations, to see on which image set better performances would be attained. The CNN demonstrated better performance on microscopic images, with 75% of the dataset being labeled correctly, compared to the macroscopic one, with 63% of the dataset being labeled correctly. These findings highlight the potential of smartphone-based imaging with specialized micro lenses to improve diagnostic accuracy for melanoma and other dermatological conditions in remote healthcare settings.
{"title":"Macro vs Micro Skin Imaging: Finding an Affordable Approach for Dermatological Care Access in Rural/Remote Areas.","authors":"Adela-Vasilica Gudiu, Lăcrămioara Stoicu-Tivadar","doi":"10.3233/SHTI241078","DOIUrl":"https://doi.org/10.3233/SHTI241078","url":null,"abstract":"<p><p>The present study explored alternative methods for photographing skin lesions in the absence of specialized instruments like dermatoscopes, aiming to enhance remote diagnostic capabilities, particularly in light of the increasing incidence of melanoma cases annually. Using two lenses attached to a smartphone camera, one macroscopic and the other microscopic, study images of nevus formations from one individual were captured, and, in the absence of a collaboration with a dermatologist, subsequently labeled as melanoma or non-melanoma using a Convolutional Neural Network (CNN) which was trained, with dermoscopic images of melanoma and non-melanoma formations, to see on which image set better performances would be attained. The CNN demonstrated better performance on microscopic images, with 75% of the dataset being labeled correctly, compared to the macroscopic one, with 63% of the dataset being labeled correctly. These findings highlight the potential of smartphone-based imaging with specialized micro lenses to improve diagnostic accuracy for melanoma and other dermatological conditions in remote healthcare settings.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"134-138"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pediatric growth hormone deficiency (PGHD) is a chronic condition where the pituitary gland fails to produce sufficient growth hormone, leading to delayed growth and developmental challenges. Patient journey maps can provide insight into pain points and potential opportunities for new or improved interventions to enhance care. However, a patient journey map does not yet exist for PGHD. Secondary data analysis was performed on interviews and focus groups from five cohorts in Sweden, the United Kingdom, Luxembourg, France, and The Netherlands. Participants included 62 patients and caregivers who used a prototype digital health solution, which was used to guide discussions. Grounded theory was used to analyze the data, resulting in a patient journey map comprising six stages: awareness, diagnosis, treatment planning, treatment initiation, treatment maintenance and transition. This provides the first detailed PGHD patient journey map, revealing emotional sensitivities and challenges at each stage, and suggesting areas for targeted interventions to improve adherence and long-term outcomes.
{"title":"The Pediatric Growth Hormone Deficiency Patient Journey: Identifying Opportunities for Digital Health Interventions.","authors":"Guido Giunti, Fulvio Michelis, Ammar Halabi, Ekaterina Koledova, Jamie Harvey, Paul Dimitri","doi":"10.3233/SHTI241066","DOIUrl":"https://doi.org/10.3233/SHTI241066","url":null,"abstract":"<p><p>Pediatric growth hormone deficiency (PGHD) is a chronic condition where the pituitary gland fails to produce sufficient growth hormone, leading to delayed growth and developmental challenges. Patient journey maps can provide insight into pain points and potential opportunities for new or improved interventions to enhance care. However, a patient journey map does not yet exist for PGHD. Secondary data analysis was performed on interviews and focus groups from five cohorts in Sweden, the United Kingdom, Luxembourg, France, and The Netherlands. Participants included 62 patients and caregivers who used a prototype digital health solution, which was used to guide discussions. Grounded theory was used to analyze the data, resulting in a patient journey map comprising six stages: awareness, diagnosis, treatment planning, treatment initiation, treatment maintenance and transition. This provides the first detailed PGHD patient journey map, revealing emotional sensitivities and challenges at each stage, and suggesting areas for targeted interventions to improve adherence and long-term outcomes.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"74-78"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Structured data are the capital of empirical health research. The value of these data relates to their quality and to their fit for use. A German guideline for the management of data quality in registries and cohort studies lists 51 quality indicators organized into the categories organization, integrity, and trueness. An update of the guideline will take into account the current view on dimensions of data, the appropriate structure for the definition of an indicator, and the collection of quality indicators itself. In the next version, the collection will explicitly address measures of metadata quality. The first step of a literature review revealed a high number of potential sources of evidence. These will be categorized into the topics dimensions, structure, and indicators respectively. Special attention will be paid to new challenges of data quality control arising from big data and artificial intelligence.
{"title":"A Collection of Data Quality Indicators for Health Research: Rationale for an Update.","authors":"Jürgen Stausberg, Sonja Harkener, Solveig Bünz","doi":"10.3233/SHTI241103","DOIUrl":"https://doi.org/10.3233/SHTI241103","url":null,"abstract":"<p><p>Structured data are the capital of empirical health research. The value of these data relates to their quality and to their fit for use. A German guideline for the management of data quality in registries and cohort studies lists 51 quality indicators organized into the categories organization, integrity, and trueness. An update of the guideline will take into account the current view on dimensions of data, the appropriate structure for the definition of an indicator, and the collection of quality indicators itself. In the next version, the collection will explicitly address measures of metadata quality. The first step of a literature review revealed a high number of potential sources of evidence. These will be categorized into the topics dimensions, structure, and indicators respectively. Special attention will be paid to new challenges of data quality control arising from big data and artificial intelligence.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"254-258"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690228","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Minerva Viguera Moreno, Maria Eugenia Marzo Sola, Ricardo Sanchez de Madariaga, Fernando Martin-Sanchez
Multiple sclerosis (MS) is a complex neurodegenerative disease with a variable prognosis that complicates effective management and treatment. This study leverages machine learning (ML) to enhance the understanding of disease progression and uncover gender-based differences in MS by analyzing clinical data integrated with patient-reported outcomes (PROMs). We conducted a prospective cohort study involving 250 MS patients at a secondary care hospital in Spain over an 18-month period. Using REDCap for data management, we collected comprehensive demographic, clinical, and PROMs data. Our analysis utilized Decision Trees, Random Forest, and Support Vector Machine algorithms to classify patients based on disease evolution and infer Expanded Disability Status Scale (EDSS) levels. Additionally, we employed propensity score matching to analyze gender differences, focusing on clinical outcomes and quality of life measures. The results could indicate that integrating diverse data sets through ML would significantly improve the diagnostic accuracy and serve as a support for clinician's decision making. Our models achieved high accuracy in classifying MS types and predicting disability levels, demonstrating the potential of ML in personalized treatment planning. Furthermore, our findings suggest notable gender differences in disease progression and response to treatment. These insights advocate for a gender-specific approach in MS management and highlight the importance of personalized medicine. This study underscores the transformative potential of ML in enhancing the understanding and management of MS through integrated data analysis.
多发性硬化症(MS)是一种复杂的神经退行性疾病,预后多变,使有效的管理和治疗变得复杂。本研究利用机器学习(ML)技术,通过分析与患者报告结果(PROMs)相结合的临床数据,加深对疾病进展的理解,并揭示多发性硬化症的性别差异。我们开展了一项前瞻性队列研究,涉及西班牙一家二级医院的 250 名多发性硬化症患者,历时 18 个月。我们使用 REDCap 进行数据管理,收集了全面的人口统计学、临床和 PROMs 数据。我们的分析采用了决策树、随机森林和支持向量机算法,根据疾病演变情况对患者进行分类,并推断出扩展残疾状态量表(EDSS)的水平。此外,我们还采用倾向得分匹配来分析性别差异,重点关注临床结果和生活质量指标。研究结果表明,通过 ML 整合不同的数据集将显著提高诊断准确性,并为临床医生的决策提供支持。我们的模型在多发性硬化症类型分类和残疾程度预测方面具有很高的准确性,证明了 ML 在个性化治疗规划方面的潜力。此外,我们的研究结果表明,在疾病进展和治疗反应方面存在明显的性别差异。这些见解主张在多发性硬化症的治疗中采用针对不同性别的方法,并强调了个性化医疗的重要性。这项研究强调了 ML 在通过综合数据分析加强对多发性硬化症的理解和管理方面的变革潜力。
{"title":"Integrating Clinical Data and Patient-Reported Outcomes for Analyzing Gender Differences and Progression in Multiple Sclerosis Using Machine Learning.","authors":"Minerva Viguera Moreno, Maria Eugenia Marzo Sola, Ricardo Sanchez de Madariaga, Fernando Martin-Sanchez","doi":"10.3233/SHTI241053","DOIUrl":"https://doi.org/10.3233/SHTI241053","url":null,"abstract":"<p><p>Multiple sclerosis (MS) is a complex neurodegenerative disease with a variable prognosis that complicates effective management and treatment. This study leverages machine learning (ML) to enhance the understanding of disease progression and uncover gender-based differences in MS by analyzing clinical data integrated with patient-reported outcomes (PROMs). We conducted a prospective cohort study involving 250 MS patients at a secondary care hospital in Spain over an 18-month period. Using REDCap for data management, we collected comprehensive demographic, clinical, and PROMs data. Our analysis utilized Decision Trees, Random Forest, and Support Vector Machine algorithms to classify patients based on disease evolution and infer Expanded Disability Status Scale (EDSS) levels. Additionally, we employed propensity score matching to analyze gender differences, focusing on clinical outcomes and quality of life measures. The results could indicate that integrating diverse data sets through ML would significantly improve the diagnostic accuracy and serve as a support for clinician's decision making. Our models achieved high accuracy in classifying MS types and predicting disability levels, demonstrating the potential of ML in personalized treatment planning. Furthermore, our findings suggest notable gender differences in disease progression and response to treatment. These insights advocate for a gender-specific approach in MS management and highlight the importance of personalized medicine. This study underscores the transformative potential of ML in enhancing the understanding and management of MS through integrated data analysis.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"17-21"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sesterterpenoids, a subset of the terpene family, exhibit notable biological activities. These natural compounds are present in a variety of organisms such as plants, fungi, bacteria, insects and marine life. The therapeutic potential and structural diversity of sesterterpenoids have attracted considerable interest in pharmacological and chemical research. This study illustrates the development of a database to structure and manage data on these compounds. The design process involves the collection of user requirements, creation of a conceptual model with and Entity-Relationship Diagram (ERD), development of a logical model, and implementation in Microsoft SQL Server 2022. Data collection began with an extensive literature review and organization in an Excel spreadsheet. The resulting database improves data acquisition, organization, and accessibility. Future work will include building a website to facilitate data entry, editing, reading and extraction, and automation of data updates via external web services.
酯萜类化合物是萜烯家族的一个分支,具有显著的生物活性。这些天然化合物存在于植物、真菌、细菌、昆虫和海洋生物等多种生物体中。酯萜类化合物的治疗潜力和结构多样性引起了药理学和化学研究的极大兴趣。本研究说明了如何开发一个数据库来构建和管理这些化合物的数据。设计过程包括收集用户需求、创建带有实体关系图(ERD)的概念模型、开发逻辑模型以及在 Microsoft SQL Server 2022 中实施。数据收集始于广泛的文献综述,并在 Excel 电子表格中进行整理。由此产生的数据库改进了数据采集、组织和可访问性。未来的工作将包括建立一个网站,以方便数据的输入、编辑、读取和提取,并通过外部网络服务实现数据更新的自动化。
{"title":"Organizing an Interdisciplinary Platform for Knowledge Sharing on a Class of Compounds of Natural Origin.","authors":"Ylenia Murgia, Valeria Iobbi, Angela Bisio, Nunziatina de Tommasi, Mauro Giacomini","doi":"10.3233/SHTI241061","DOIUrl":"https://doi.org/10.3233/SHTI241061","url":null,"abstract":"<p><p>Sesterterpenoids, a subset of the terpene family, exhibit notable biological activities. These natural compounds are present in a variety of organisms such as plants, fungi, bacteria, insects and marine life. The therapeutic potential and structural diversity of sesterterpenoids have attracted considerable interest in pharmacological and chemical research. This study illustrates the development of a database to structure and manage data on these compounds. The design process involves the collection of user requirements, creation of a conceptual model with and Entity-Relationship Diagram (ERD), development of a logical model, and implementation in Microsoft SQL Server 2022. Data collection began with an extensive literature review and organization in an Excel spreadsheet. The resulting database improves data acquisition, organization, and accessibility. Future work will include building a website to facilitate data entry, editing, reading and extraction, and automation of data updates via external web services.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"53-57"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Norbert Gal-Nadasan, Vasile Stoicu-Tivadar, Emanuela Gal-Nadasan, Anca Raluca Dinu
This paper proposes to create an Robotic Process Automation style application that can digitalize and extract data from handwritten medical forms. The RPA robot uses OpenAI ChatGPT4o model to extract handwritten medical data and transform it into typed data. The handwritten data is transcribed correctly at a rate of 100%. The data interpretation is accomplished by the UiPath machine learning API. By creating new nonstandard form templates and associated taxonomies the system can be scaled as desired. After the data extraction process the saved data can be sent to a database, spreadsheet. The access to this medical data is restricted to the physicians and medical nurses employed at the medical facility.
本文建议创建一个机器人流程自动化风格的应用程序,它可以从手写医疗表格中数字化并提取数据。RPA 机器人使用 OpenAI ChatGPT4o 模型提取手写医疗数据,并将其转换为打字数据。手写数据的转录正确率达到 100%。数据解释由 UiPath 机器学习 API 完成。通过创建新的非标准表单模板和相关分类标准,该系统可根据需要进行扩展。数据提取过程结束后,保存的数据可以发送到数据库或电子表格中。这些医疗数据的访问权限仅限于医疗机构的医生和护士。
{"title":"Handwritten Data Extraction Using OpenAI ChatGPT4o and Robotic Process Automation.","authors":"Norbert Gal-Nadasan, Vasile Stoicu-Tivadar, Emanuela Gal-Nadasan, Anca Raluca Dinu","doi":"10.3233/SHTI241101","DOIUrl":"https://doi.org/10.3233/SHTI241101","url":null,"abstract":"<p><p>This paper proposes to create an Robotic Process Automation style application that can digitalize and extract data from handwritten medical forms. The RPA robot uses OpenAI ChatGPT4o model to extract handwritten medical data and transform it into typed data. The handwritten data is transcribed correctly at a rate of 100%. The data interpretation is accomplished by the UiPath machine learning API. By creating new nonstandard form templates and associated taxonomies the system can be scaled as desired. After the data extraction process the saved data can be sent to a database, spreadsheet. The access to this medical data is restricted to the physicians and medical nurses employed at the medical facility.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"245-249"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The development of medical science allows the treatment of more and more health problems that in the past were not a factor of consumption of health resources, because at that time medical science did not have protocols for their treatment. Health problems that are now treatable, hereafter referred as "new health problems", often affect large population groups and require increased consumption of health resources. It therefore becomes necessary to increase the number of staff providing health services (doctors, nurses, etc.) and other resources. This raises the question: is it feasible to manage the "new health problems" by the existing medical staff? If not, are there other solutions? Could technology help the existing Medical Staff to sufficiently manage the "new health problems"? We will examine a pilot system "Recording and visualizing of outpatient monitoring data with smart mobile phones", which seeks to ensure the competence of existing medical staff in the effective treatment of the ever-increasing volume of transplant patients.
{"title":"Use Technology to Help Medical Staff Treat \"New Health Problems\" Arising Constantly.","authors":"Nikitas N Karanikolas","doi":"10.3233/SHTI241067","DOIUrl":"https://doi.org/10.3233/SHTI241067","url":null,"abstract":"<p><p>The development of medical science allows the treatment of more and more health problems that in the past were not a factor of consumption of health resources, because at that time medical science did not have protocols for their treatment. Health problems that are now treatable, hereafter referred as \"new health problems\", often affect large population groups and require increased consumption of health resources. It therefore becomes necessary to increase the number of staff providing health services (doctors, nurses, etc.) and other resources. This raises the question: is it feasible to manage the \"new health problems\" by the existing medical staff? If not, are there other solutions? Could technology help the existing Medical Staff to sufficiently manage the \"new health problems\"? We will examine a pilot system \"Recording and visualizing of outpatient monitoring data with smart mobile phones\", which seeks to ensure the competence of existing medical staff in the effective treatment of the ever-increasing volume of transplant patients.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"79-83"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Healthcare systems worldwide face escalating costs and demographic changes, necessitating effective evaluation tools to understand their underlying challenges. Switzerland's high-quality yet costly healthcare system underscores the need for robust assessment methods. Existing international rankings often lack transparency and comparability, highlighting the value of structured frameworks like the Health System Performance Assessment (HSPA) by the World Health Organization (WHO). This framework evaluates healthcare systems across multiple dimensions including governance, resource generation, financing, and service delivery. This paper aims to integrate Swiss healthcare indicators from the Swiss Health Observatory (Obsan) into the HSPA framework, addressing the central research question: How can these indicators be mapped to the HSPA framework, and what insights does this integration provide? Our methodology includes selecting and categorizing Obsan indicators, manually mapping them to HSPA sub-functions, and validating these mappings using word embeddings and cosine similarity. An R Shiny application was developed for interactive visualization. Results demonstrate accurate indicator assignment, enabling intuitive visualization and enhancing data structuring.
{"title":"Mapping of Health System Performance Indicators to the WHO HSPA Framework.","authors":"Lucien Adam, Anthéa Helene Leung, Murat Sariyar","doi":"10.3233/SHTI241050","DOIUrl":"https://doi.org/10.3233/SHTI241050","url":null,"abstract":"<p><p>Healthcare systems worldwide face escalating costs and demographic changes, necessitating effective evaluation tools to understand their underlying challenges. Switzerland's high-quality yet costly healthcare system underscores the need for robust assessment methods. Existing international rankings often lack transparency and comparability, highlighting the value of structured frameworks like the Health System Performance Assessment (HSPA) by the World Health Organization (WHO). This framework evaluates healthcare systems across multiple dimensions including governance, resource generation, financing, and service delivery. This paper aims to integrate Swiss healthcare indicators from the Swiss Health Observatory (Obsan) into the HSPA framework, addressing the central research question: How can these indicators be mapped to the HSPA framework, and what insights does this integration provide? Our methodology includes selecting and categorizing Obsan indicators, manually mapping them to HSPA sub-functions, and validating these mappings using word embeddings and cosine similarity. An R Shiny application was developed for interactive visualization. Results demonstrate accurate indicator assignment, enabling intuitive visualization and enhancing data structuring.</p>","PeriodicalId":94357,"journal":{"name":"Studies in health technology and informatics","volume":"321 ","pages":"2-6"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142690290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}